Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.47 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.47 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.47 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31741945 | 1.00 | PTGDR2 (0.50) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL31741946 | 1.00 | PTGDR2 (0.50) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL3422472 | 0.96 | PTGDR2 (0.53) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL20740894 | 0.92 | PTGDR2 (0.50) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL13682554 | 0.90 | GABRA1 (0.50) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL10929186 | 0.90 | GABRA1 (0.50) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL12855308 | 0.88 | PTGDR2 (0.50) | PTGDR2TSHRGABRA1GABRG2GABRB3 | |
| SCHEMBL25774578 | 0.88 | ABCG2 (0.51) | PTGDR2TSHRCYP19A1METAP2ABCB1 | |
| SCHEMBL25774610 | 0.88 | MAPK1 (0.47) | PTGDR2GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL3422469 | 0.87 | TSHR (0.59) | PTGDR2TSHRGABRA1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2456555-A1 | METHOD FOR OXIDIZING METHANE | Studiengesellschaft Kohle MbH (DE) | 2012-05-30 | — | — | EP | claimed |
| US-20120130071-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2012-05-24 | — | — | US | claimed |
| WO-2011009429-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-01-27 | — | — | WO | claimed |
| EP-2456555-A1 | METHOD FOR OXIDIZING METHANE | Studiengesellschaft Kohle MbH (DE) | 2012-05-30 | — | — | EP | disclosed |
| US-20120130071-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2012-05-24 | — | — | US | disclosed |
| WO-2011009429-A1 | METHOD FOR OXIDIZING METHANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130071-A1 | METHOD FOR OXIDIZING METHANE | TST, MGMT, PMS2 | PTGDR2 3004/4885TSHR 3773/4885GABRA1 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.